Erratum: Targeting CD137 enhances the efficacy of cetuximab(J Clin Invest. (2019)129:6 (2595-2595) DOI: 10.1172/JCI129689)

Holbrook E. Kohrt, A. Dimitrios Colevas, Roch Houot, Kipp Weiskopf, Matthew J. Goldstein, Peder Lund, Antonia Mueller, Idit Sagiv-Barfi, Aurelien Marabelle, Ruth Lira, Emily Troutner, Lori Richards, Amanda Rajapaska, Jonathan Hebb, Cariad Chester, Erin Waller, Anton Ostashko, Wen Kai Weng, Lieping Chen, Debra CzerwinskiYang Xin Fu, John Sunwoo, Ronald Levy

Research output: Contribution to journalComment/debate

Abstract

Stanford University School of Medicine recently notified the JCI of concerns regarding Figure 4, B, C, and E, Figure 5, B, D, and F, and Figure 6B and indicated that the original source data for these figures could not be located. In accordance with the institutional recommendation, the JCI is retracting this article.

Original languageEnglish (US)
Number of pages1
JournalJournal of Clinical Investigation
Volume129
Issue number6
DOIs
StatePublished - Jun 3 2019

Fingerprint

Information Storage and Retrieval
Medicine
Cetuximab

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Erratum : Targeting CD137 enhances the efficacy of cetuximab(J Clin Invest. (2019)129:6 (2595-2595) DOI: 10.1172/JCI129689). / Kohrt, Holbrook E.; Colevas, A. Dimitrios; Houot, Roch; Weiskopf, Kipp; Goldstein, Matthew J.; Lund, Peder; Mueller, Antonia; Sagiv-Barfi, Idit; Marabelle, Aurelien; Lira, Ruth; Troutner, Emily; Richards, Lori; Rajapaska, Amanda; Hebb, Jonathan; Chester, Cariad; Waller, Erin; Ostashko, Anton; Weng, Wen Kai; Chen, Lieping; Czerwinski, Debra; Fu, Yang Xin; Sunwoo, John; Levy, Ronald.

In: Journal of Clinical Investigation, Vol. 129, No. 6, 03.06.2019.

Research output: Contribution to journalComment/debate

Kohrt, HE, Colevas, AD, Houot, R, Weiskopf, K, Goldstein, MJ, Lund, P, Mueller, A, Sagiv-Barfi, I, Marabelle, A, Lira, R, Troutner, E, Richards, L, Rajapaska, A, Hebb, J, Chester, C, Waller, E, Ostashko, A, Weng, WK, Chen, L, Czerwinski, D, Fu, YX, Sunwoo, J & Levy, R 2019, 'Erratum: Targeting CD137 enhances the efficacy of cetuximab(J Clin Invest. (2019)129:6 (2595-2595) DOI: 10.1172/JCI129689)', Journal of Clinical Investigation, vol. 129, no. 6. https://doi.org/10.1172/JCI73014
Kohrt, Holbrook E. ; Colevas, A. Dimitrios ; Houot, Roch ; Weiskopf, Kipp ; Goldstein, Matthew J. ; Lund, Peder ; Mueller, Antonia ; Sagiv-Barfi, Idit ; Marabelle, Aurelien ; Lira, Ruth ; Troutner, Emily ; Richards, Lori ; Rajapaska, Amanda ; Hebb, Jonathan ; Chester, Cariad ; Waller, Erin ; Ostashko, Anton ; Weng, Wen Kai ; Chen, Lieping ; Czerwinski, Debra ; Fu, Yang Xin ; Sunwoo, John ; Levy, Ronald. / Erratum : Targeting CD137 enhances the efficacy of cetuximab(J Clin Invest. (2019)129:6 (2595-2595) DOI: 10.1172/JCI129689). In: Journal of Clinical Investigation. 2019 ; Vol. 129, No. 6.
@article{8e4f17fbbc2840e4bfbb198538d52c61,
title = "Erratum: Targeting CD137 enhances the efficacy of cetuximab(J Clin Invest. (2019)129:6 (2595-2595) DOI: 10.1172/JCI129689)",
abstract = "Stanford University School of Medicine recently notified the JCI of concerns regarding Figure 4, B, C, and E, Figure 5, B, D, and F, and Figure 6B and indicated that the original source data for these figures could not be located. In accordance with the institutional recommendation, the JCI is retracting this article.",
author = "Kohrt, {Holbrook E.} and Colevas, {A. Dimitrios} and Roch Houot and Kipp Weiskopf and Goldstein, {Matthew J.} and Peder Lund and Antonia Mueller and Idit Sagiv-Barfi and Aurelien Marabelle and Ruth Lira and Emily Troutner and Lori Richards and Amanda Rajapaska and Jonathan Hebb and Cariad Chester and Erin Waller and Anton Ostashko and Weng, {Wen Kai} and Lieping Chen and Debra Czerwinski and Fu, {Yang Xin} and John Sunwoo and Ronald Levy",
year = "2019",
month = "6",
day = "3",
doi = "10.1172/JCI73014",
language = "English (US)",
volume = "129",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "6",

}

TY - JOUR

T1 - Erratum

T2 - Targeting CD137 enhances the efficacy of cetuximab(J Clin Invest. (2019)129:6 (2595-2595) DOI: 10.1172/JCI129689)

AU - Kohrt, Holbrook E.

AU - Colevas, A. Dimitrios

AU - Houot, Roch

AU - Weiskopf, Kipp

AU - Goldstein, Matthew J.

AU - Lund, Peder

AU - Mueller, Antonia

AU - Sagiv-Barfi, Idit

AU - Marabelle, Aurelien

AU - Lira, Ruth

AU - Troutner, Emily

AU - Richards, Lori

AU - Rajapaska, Amanda

AU - Hebb, Jonathan

AU - Chester, Cariad

AU - Waller, Erin

AU - Ostashko, Anton

AU - Weng, Wen Kai

AU - Chen, Lieping

AU - Czerwinski, Debra

AU - Fu, Yang Xin

AU - Sunwoo, John

AU - Levy, Ronald

PY - 2019/6/3

Y1 - 2019/6/3

N2 - Stanford University School of Medicine recently notified the JCI of concerns regarding Figure 4, B, C, and E, Figure 5, B, D, and F, and Figure 6B and indicated that the original source data for these figures could not be located. In accordance with the institutional recommendation, the JCI is retracting this article.

AB - Stanford University School of Medicine recently notified the JCI of concerns regarding Figure 4, B, C, and E, Figure 5, B, D, and F, and Figure 6B and indicated that the original source data for these figures could not be located. In accordance with the institutional recommendation, the JCI is retracting this article.

UR - http://www.scopus.com/inward/record.url?scp=85066607597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066607597&partnerID=8YFLogxK

U2 - 10.1172/JCI73014

DO - 10.1172/JCI73014

M3 - Comment/debate

C2 - 24837434

AN - SCOPUS:85066607597

VL - 129

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 6

ER -